Skip to main content

Advertisement

Log in

Surgical Site Infection after Breast Surgery: Impact of 2010 CDC Reporting Guidelines

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Reported surgical site infection (SSI) rates after breast operations ranges 0.8–26 % in the literature. The aims of the present study were to characterize SSI after breast/axillary operations and determine the impact on the SSI rate of the 2010 Centers for disease control and Prevention (CDC) reporting guidelines that now specifically exclude cellulitis.

Methods

Retrospective chart review identified 368 patients with 449 operated sides between July 2004 and June 2006. SSI was defined by CDC criteria: purulent drainage (category 1), positive aseptically collected culture (category 2), signs of inflammation with opening of incision and absence of negative culture (category 3), and physician diagnosis of infection (category 4). The impact of excluding cellulitis was assessed.

Results

Prior CDC reporting guidelines revealed that among 368 patients, 32 (8.7 %) experienced SSI in 33 (7.3 %) of 449 operated sides. Of these, 11 (33 %) met CDC criteria 1–3, while 22 (67 %) met CDC criterion 4. Excluding cellulitis cases per 2010 CDC SSI reporting guidelines eliminates 21 of the 22 infections previously meeting CDC criterion 4. Under the new reporting guidelines, the SSI rate is 12 (2.7 %) of 449 operated sides. SSI rates varied by procedure, but these differences were not statistically significant.

Conclusions

Cellulitis after breast and axillary surgery is much more common than other criteria for SSI, and SSI rates are reduced almost threefold if cellulitis cases are excluded. Recently revised CDC reporting guidelines may result in underestimates of the clinical burden of SSI after breast/axillary surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Murthy BL, Thomson CS, Dodwell D, et al. Postoperative wound complications and systemic recurrence in breast cancer. Br J Cancer. 2007;97:1211–7.

    Article  PubMed  CAS  Google Scholar 

  2. Indelicato D, Grobmyer SR, Newlin H, et al. Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer. Surgery. 2007;141:645–53.

    Article  PubMed  Google Scholar 

  3. Prospero E, Cavicchi A, Bacelli S, et al. Surveillance for surgical site infection after hospital discharge: a surgical procedure-specific perspective. Infect Control Hosp Epidemiol. 2006;27:1313–7.

    Article  PubMed  CAS  Google Scholar 

  4. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37:783–805.

    Article  PubMed  Google Scholar 

  5. Nahabedian MY, Tsangaris T, Momen B, et al. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg. 2003;112:467–76.

    Article  PubMed  Google Scholar 

  6. Ruvalcaba-Limon E, Robles-Vidal C, Poitevin-Chacon A, et al. Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: a case-control analysis. Breast Cancer Res Treat. 2006;95:147–52.

    Article  PubMed  Google Scholar 

  7. Vilar-Compte D, Jacquemin B, Robles-Vidal C, et al. Surgical site infections in breast surgery: case-control study. World J Surg. 2004;28:242–6.

    Article  PubMed  Google Scholar 

  8. Neumayer L, Schifftner TL, Henderson WG, et al. Breast cancer surgery in Veterans Affairs and selected university medical centers: results of the patient safety in surgery study. J Am Coll Surg. 2007;204:1235–41.

    Article  PubMed  Google Scholar 

  9. Centers for Disease Control and Prevention. Surgical site infection event SSIS. Guidelines and procedures for monitoring SSI. http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf.

  10. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital infection control practices advisory committee. Am J Infect Control. 1999;27:97–132.

    Article  Google Scholar 

  11. Throckmorton AD, Hoskin T, Boostrom SY, et al. Complications associated with postoperative antibiotic prophylaxis after breast surgery. Am J Surg. 2009;198:553–6.

    Article  PubMed  Google Scholar 

  12. Zakaria S, Hoskin TL, Degnim AC. Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer. Am J Surg. 2008;196:228–33.

    Article  PubMed  Google Scholar 

  13. Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25:3657–63.

    Article  PubMed  Google Scholar 

  14. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98:599–609.

    Article  PubMed  Google Scholar 

  15. Garwood ER, Moore D, Ewing C, et al. Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients. Ann Surg. 2009;249:26–32.

    Article  PubMed  Google Scholar 

  16. Goffman TE, Laronga C, Wilson L, et al. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J. 2004;10:405–11.

    Article  PubMed  Google Scholar 

  17. American College of Surgeons. National surgical quality improvement program. http://www.acsnsqip.org.

  18. Weiss CA 3rd, Statz CL, Dahms RA, et al. Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds. Arch Surg. 1999;134:1041–8.

    Article  PubMed  Google Scholar 

  19. Rey JE, Gardner SM, Cushing RD. Determinants of surgical site infection after breast biopsy. Am J Infect Control. 2005;33:126–9.

    Article  PubMed  Google Scholar 

  20. Centers for Medicare and Medicaid Services. CMS improves patient safety for Medicare and Medicaid by addressing never events. August 4, 2008. http://www.cms.gov/apps/media/press/factsheet.asp?Counter=3224&intNumPerPage=10&checkDate=&checkKey=2&srchType=2&numDays=0&srchOpt=0&srchData=never&keywordType=All&chkNewsType=6&intPage=&showAll=1&pYear=&year=2007&desc=&cboOrder=date.

Download references

Acknowledgment

A.C.D. is supported by the CA90628-08 Paul Calabresi Award for Clinical–Translational Research (K12) via the Mayo Clinic Cancer Center. This project was also supported by NIH/NCRR CTSA grant UL1 RR024150. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Sincere appreciation to Marilyn Churchward for assistance with manuscript preparation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amy C. Degnim MD, FACS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Degnim, A.C., Throckmorton, A.D., Boostrom, S.Y. et al. Surgical Site Infection after Breast Surgery: Impact of 2010 CDC Reporting Guidelines. Ann Surg Oncol 19, 4099–4103 (2012). https://doi.org/10.1245/s10434-012-2448-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-012-2448-6

Keywords

Navigation